BioCentury | Apr 30, 2012
Finance

Analyst tracks

...and biotechnology research analyst. Banker tracks Michael Manocchio was promoted to VP from associate at Morgan Joseph TriArtisan...
BioCentury | Mar 12, 2012
Financial News

Lpath completes private placement of units

...$9.3 million Units: 12.4 million Price: $0.75 (unit) Shares after offering: 73.7 million Placement agents: Morgan Joseph TriArtisan...
BioCentury | Jan 30, 2012
Financial News

Tvax Biomedical amends IPO

...shares at $9-$11 per share. The company also added Aegis as an underwriter and dropped Morgan Joseph TriArtisan...
BioCentury | Jan 2, 2012
Financial News

Lpath amends follow-on

...million Price prior: $1.15 Underwriters: Morgan Joseph TriArtisan; Summer Street Note: Lpath amended its offering to add Morgan Joseph TriArtisan...
BioCentury | Nov 14, 2011
Finance

Heartland IPOs

...$4.6 million in cash at June 30. Underwriters are Roth Capital Partners; Cantor Fitzgerald; and Morgan Joseph TriArtisan. ...
BioCentury | Nov 14, 2011
Financial News

Tvax Biomedical proposes IPO

...raised: Up to $40 million Shares: TBD Price: TBD Underwriters: Roth Capital Partners; Cantor Fitzgerald; Morgan Joseph TriArtisan WIR...
BioCentury | Nov 8, 2011
Financial News

Tvax Biomedical files for IPO

...up to $40 million in an IPO underwritten by Roth Capital Partners; Cantor Fitzgerald; and Morgan Joseph TriArtisan...
BioCentury | Jul 25, 2011
Financial News

NeoStem completes follow-on

...Units: 13.8 million Price: $1.20 (unit) Shares after offering: 96.6 million Underwriters: Lazard; JMP Securities; Morgan Joseph TriArtisan...
BioCentury | Jul 20, 2011
Financial News

NeoStem raises $16.5M

Cell therapy company NeoStem Inc. (NYSE-A:NBS) raised $16.5 million through the sale of 13.8 million units at $1.20 in a follow-on underwritten by Lazard; JMP; Morgan Joseph; TriArtisan; Maxim Group; and National Securities. Each unit...
BioCentury | Jun 13, 2011
Finance

Banker, Analyst, Venture Tracks

...for Europe. He was the head of pharmaceutical research at Morgan Stanley. Raghuram Selvaraju joined Morgan Joseph TriArtisan...
Items per page:
1 - 10 of 13
BioCentury | Apr 30, 2012
Finance

Analyst tracks

...and biotechnology research analyst. Banker tracks Michael Manocchio was promoted to VP from associate at Morgan Joseph TriArtisan...
BioCentury | Mar 12, 2012
Financial News

Lpath completes private placement of units

...$9.3 million Units: 12.4 million Price: $0.75 (unit) Shares after offering: 73.7 million Placement agents: Morgan Joseph TriArtisan...
BioCentury | Jan 30, 2012
Financial News

Tvax Biomedical amends IPO

...shares at $9-$11 per share. The company also added Aegis as an underwriter and dropped Morgan Joseph TriArtisan...
BioCentury | Jan 2, 2012
Financial News

Lpath amends follow-on

...million Price prior: $1.15 Underwriters: Morgan Joseph TriArtisan; Summer Street Note: Lpath amended its offering to add Morgan Joseph TriArtisan...
BioCentury | Nov 14, 2011
Finance

Heartland IPOs

...$4.6 million in cash at June 30. Underwriters are Roth Capital Partners; Cantor Fitzgerald; and Morgan Joseph TriArtisan. ...
BioCentury | Nov 14, 2011
Financial News

Tvax Biomedical proposes IPO

...raised: Up to $40 million Shares: TBD Price: TBD Underwriters: Roth Capital Partners; Cantor Fitzgerald; Morgan Joseph TriArtisan WIR...
BioCentury | Nov 8, 2011
Financial News

Tvax Biomedical files for IPO

...up to $40 million in an IPO underwritten by Roth Capital Partners; Cantor Fitzgerald; and Morgan Joseph TriArtisan...
BioCentury | Jul 25, 2011
Financial News

NeoStem completes follow-on

...Units: 13.8 million Price: $1.20 (unit) Shares after offering: 96.6 million Underwriters: Lazard; JMP Securities; Morgan Joseph TriArtisan...
BioCentury | Jul 20, 2011
Financial News

NeoStem raises $16.5M

Cell therapy company NeoStem Inc. (NYSE-A:NBS) raised $16.5 million through the sale of 13.8 million units at $1.20 in a follow-on underwritten by Lazard; JMP; Morgan Joseph; TriArtisan; Maxim Group; and National Securities. Each unit...
BioCentury | Jun 13, 2011
Finance

Banker, Analyst, Venture Tracks

...for Europe. He was the head of pharmaceutical research at Morgan Stanley. Raghuram Selvaraju joined Morgan Joseph TriArtisan...
Items per page:
1 - 10 of 13